PARIS--(BUSINESS WIRE)--Iktos, a company specialized in Artificial Intelligence for new drug design today announced collaboration agreement in AI for new drug design with Chiesi Group, the ...
DeepMirror, a University of Cambridge spin-out company developing intuitive design software for the discovery of novel therapeutic drugs, today announced the launch of its Early Access Programme after ...
If a picture is worth 1,000 words, a 3D model of a new drug candidate is worth far more. After all, such a model can help the drug candidate’s designers make sense of their voluminous data—which ...
New technologies continue to emerge that improve care for patients taking prescription medications. On September 18, 2023, five years after the Food and Drug Administration sought initial public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results